HomeEGRX • NASDAQ
add
Eagle Pharmaceuticals Inc
Previous close
$4.55
Day range
$4.54 - $5.01
Year range
$4.10 - $30.40
Market cap
61.68M USD
Avg Volume
157.78K
P/E ratio
5.24
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 64.65M | -12.80% |
Operating expense | 37.48M | 21.82% |
Net income | 5.16M | 154.65% |
Net profit margin | 7.99 | 162.67% |
Earnings per share | 1.18 | -24.36% |
EBITDA | 15.88M | -25.56% |
Effective tax rate | 44.46% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 15.35M | -58.01% |
Total assets | 404.82M | 6.04% |
Total liabilities | 152.78M | 6.27% |
Total equity | 252.04M | — |
Shares outstanding | 12.99M | — |
Price to book | 0.24 | — |
Return on assets | 6.29% | — |
Return on capital | 7.97% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | 5.16M | 154.65% |
Cash from operations | -126.00K | -100.29% |
Cash from investing | -6.00K | 99.99% |
Cash from financing | -6.41M | -1,096.08% |
Net change in cash | -6.54M | 80.15% |
Free cash flow | 2.62M | -93.52% |
About
Founded
2007
Headquarters
Website
Employees
134